US 8506959
Prevention and treatment of synucleinopathic and amyloidogenic disease
granted A61KA61K2039/505A61K38/1709
Quick answer
US patent 8506959 (Prevention and treatment of synucleinopathic and amyloidogenic disease) held by The Regents of the University of California expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61K38/1709, A61K39/00, A61P